April 18, 2017
Attack the Gap-New Immunotherapy May Help the Body Fight Ovarian Cancer
It was only when Kathi Schroeder took to the bone-chilling streets of Cedar Rapids, Iowa, on her bike last January that she noticed something was not right. “I was having trouble breathing; just taking a deep breath was difficult,” she remembers. Kathi went to her local doctor’s office and was prescribed a round of antibiotics […]
Tags: clinical trials, immunotherapy, Matthew Block, Mayo Clinic Cancer Center, ovarian cancer
October 27, 2016
“The Pill” associated with better ovarian cancer outcomes
If a woman takes oral contraceptives, it provides not only reduced risk of developing ovarian cancer, but also better outcomes if she does get this deadly cancer. “Multiple studies from a variety of sources have indicated that oral contraceptives are associated with a reduced risk of ovarian cancer, one of the most deadly cancers in […]
September 13, 2016
What is stopping patients from enrolling in clinical trials?
Clinical trials are the mechanism through which new and promising therapies for safe, effective cancer treatment ultimately become available. Not only do trials help identify new or best-practice therapeutic treatment options, but the act of participating in a trial has been shown to actually improve survival. One of the most promising areas of research to […]
Tags: Carmen Radecki Breitkopf, Center for the Science of Health Care Delivery, clinical trials, immunotherapy, Mayo Clinic Cancer Center, measles virus, ovarian cancer